Topics

University of Birmingham spin-out secures £2m to develop medical diagnostic technology

14:24 EST 9 Nov 2019 | Synbiobeta

Investment will enable the company to invest in technical resource and accelerate product development Birmingham-based Linear Diagnostics Limited (LDL) has secured £2m of investment from MEIF and other investors to develop new platform technology for medical diagnostic testing. Following extensive research, the spin-out from the University of Birmingham is to create a platform that is able to provide multiple diagnoses […]

The post University of Birmingham spin-out secures £2m to develop medical diagnostic technology appeared first on SynBioBeta.

Original Article: University of Birmingham spin-out secures £2m to develop medical diagnostic technology

NEXT ARTICLE

More From BioPortfolio on "University of Birmingham spin-out secures £2m to develop medical diagnostic technology"

Quick Search